Table 2.
No. | Elizabethkingia spp. | Clinical Presentation | Antibiotic Susceptibility (Susceptible Drugs) | Antibiotic Use | Removal of Catheter | Survival |
---|---|---|---|---|---|---|
1 | E. anophelis | Spontaneous bacterial peritonitis | Pipercacillin/tazobactam, Cefepime, Cefoperazone/sulbactam; TMP/SMX * | TMP/SMX+ Levofloxacin, then Piperacillin/tazobactam | No catheter | Expired |
2 | E. anophelis | Suspected spontaneous bacterial peritonitis | Ciprofloxacin, Piperacillin/tazobactam, TMP/SMX, Cefepime | Ciprofloxacin and Piperacillin/tazobactam | No catheter | Survived |
3 | E. meningoseptica | Intra-abdominal infection with subphrenic fluid accumulation | Ciprofloxacin, Minocycline, Tigecycline, TMP/SMX | Ciprofloxacin and metronidazole | NA | Survived |
4 | E. meningoseptica | Acute cholangitis | NA | Levofloxacin and metronidazole | NA | Survived |
5 | E. meningoseptica | Biliary tract infection with sepsis | NA | Levofloxacin | NA | Survived |
6 | E. meningoseptica | CAPD peritonitis | Cefoperazone/sulbactam, Ciprofloxacin, Levofloxacin, Minocycline, TMP/SMX | PO TMP/SMX + IV Cefoperazone/sulbactam, then shift to PO Minocycline + IV Cefoperazone/sulbactam | Removal of CAPD tube. | Survived |
7 | E. meningoseptica (previously Chryseobacterium meningoseptica) | CAPD peritonitis with Tenckhoff tube infection | Gentamicin, Ciprofloxacin, Piperacillin-tazobactam, Levofloxacin | Piperacillin-tazobactam, then shift to Levofloxacin | Removal of CAPD tube. | Survived |
8 | E. meningoseptica | CAPD peritonitis | Cefoperazone-sulbactam and nalidixic acid | Cefoperazone-sulbactam | NA | Survived |
9 | E. meningoseptica | Peritonitis, secondary to uterine perforation | TMP/SMX | TMP/SMX, Piperacillin- tazobactam, amikacin, teicoplanin and metronidazole | No catheter | Survived |
* TMP/SMX-susceptible at first but became resistant in repeated blood culture and ascites culture; NA, nonavailable; CAPD, Continuous Ambulatory Peritoneal Dialysis; TMP/SMX, Trimethoprim/sulfamethoxazole.